1232.8000 12.50 (1.02%)
NSE Aug 13, 2025 11:19 AM
Volume: 138.1K
 

1232.80
1.02%
ICICI Securities Limited
Q3FY19 results were higher than I-direct estimates on profitability front while revenues were lower mainly due to lower US sales. Revenues were muted at | 3864.6 crore (I-direct estimate: | 4015 crore). Growth of 10% in domestic market to | 674.1 crore (I-direct estimate: | 674 crore) and 25.0% YoY growth in Russia & CIS to | 550 crore (I-direct estimate: | 550 crore) were largely offset by 7.7% fall in US sales to | 1483.2 crore (I-direct estimate: | 1600 crore) EBITDA margins remained at 20.8% YoY but came in 212 bps higher...
Dr. Reddy's Laboratories Ltd. is trading below all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended